Description

[3aS,(-)]-2-[[4-O-Aminocarbonyl-2-[methyl[(dimethylamino)acetyl]amino]-2-deoxy-β-D-gulopyranosyl]amino]-1,3aβ,5,6,7,7aα-hexahydro-7β-hydroxy-4H-imidazo[4,5-c]pyridine-4-one is a complex, high-purity nucleoside analog derivative of significant interest in advanced pharmaceutical research and development. Its intricate molecular architecture, featuring a modified sugar moiety and an imidazopyridine core, makes it a critical intermediate for synthesizing novel therapeutic agents. This compound is primarily utilized by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on antiviral and anticancer drug discovery pipelines.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel nucleoside-based antiviral and anticancer drug candidates.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies to investigate metabolic pathways and mechanisms of action.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to optimize the potency and selectivity of lead compounds.
• Process Development: Acts as a reference standard or starting material for scaling up synthetic routes under cGMP conditions.
• Academic Research: Utilized in universities and research institutes for exploring new chemical entities and their biological activities.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.

Basic Information

Product Name	[3aS,(-)]-2-[[4-O-Aminocarbonyl-2-[methyl[(dimethylamino)acetyl]amino]-2-deoxy-β-D-gulopyranosyl]amino]-1,3aβ,5,6,7,7aα-hexahydro-7β-hydroxy-4H-imidazo[4,5-c]pyridine-4-one
CAS No.	97816-59-6
Molecular Formula	C19H29N7O7
Molecular Weight	467.48 g/mol
Synonyms	(-)-2-[[4-O-Carbamoyl-2-[methyl[(dimethylamino)acetyl]amino]-2-deoxy-β-D-gulopyranosyl]amino]-1,3a,5,6,7,7a-hexahydro-7-hydroxy-4H-imidazo[4,5-c]pyridin-4-one; (3aS)-2-[[4-O-Aminocarbonyl-2-[methyl[(dimethylamino)acetyl]amino]-2-deoxy-β-D-gulopyranosyl]amino]-1,3a,5,6,7,7a-hexahydro-7-hydroxy-4H-imidazo[4,5-c]pyridin-4-one; 4H-Imidazo[4,5-c]pyridine-4-one, 1,3a,5,6,7,7a-hexahydro-2-[[4-O-(aminocarbonyl)-2-[methyl[(dimethylamino)acetyl]amino]-2-deoxy-β-D-gulopyranosyl]amino]-7-hydroxy-, (3aS,7β,7aα)-; Nucleoside Analog Derivative; Modified Gulopyranosyl Imidazopyridinone
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality protocols to ensure batch-to-batch consistency and reliability for critical research applications. Quality is verified through comprehensive analytical techniques including HPLC, NMR, and mass spectrometry. A Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment. We support development under quality systems suitable for cGMP compliance for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed in a dry environment. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH guidelines
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.